Incorporation of TTR levels in the screening programs for hereditary cardiac amyloidosis may be especially beneficial considering that the V142I variant is a common genetic variant with a carrier prevalence of 3–4% among Black individuals14–16. Here, TTR is linked to cardiac amyloidosis.